Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic / 中华医学遗传学杂志
Chinese Journal of Medical Genetics
; (6): 359-366, 2020.
Article
Dans Zh
| WPRIM
| ID: wpr-828323
Responsable en Bibliothèque :
WPRO
ABSTRACT
Since December 2019, a series of highly infectious cases of unexplained pneumonia have been discovered in Wuhan, Hubei Province, which have been confirmed as '2019 corona virus disease' caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus can invade many human systems including the lungs. Patients with central nervous system involvement may show a series of neurological symptoms, which is easy to be misdiagnosed and neglected, thereby increasing the risk of SARS-CoV-2 transmission. Hereditary ataxia is a large group of neurodegenerative diseases with great clinical and genetic heterogeneity and high mortality and disability. In view of the seriousness of the COVID-19 epidemic, a series of prevention and control measures adopted by the government have restricted the follow-up, diagnosis and treatment of patients by the hospitals, which has a great impact on their mental and physical health. In order to standardize the management of patients during the prevention and control of COVID-19 epidemic, the Specialized Committee of Neurogenetics of the Neurophysician Branch of Chinese Medical Doctor Association has formulated this consensus, with an aim to help patients to overcome the difficulties and pass the epidemic prevention period safely.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Pneumopathie virale
/
Thérapeutique
/
Virologie
/
Dégénérescences spinocérébelleuses
/
Chine
/
État de santé
/
Santé mentale
/
Épidémiologie
/
Infections à coronavirus
/
Consensus
Type d'étude:
Diagnostic_studies
/
Guideline
Limites du sujet:
Humans
Pays comme sujet:
Asia
langue:
Zh
Texte intégral:
Chinese Journal of Medical Genetics
Année:
2020
Type:
Article